Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1997;75(3):413–416. doi: 10.1038/bjc.1997.67

Characteristics of the menstrual cycle at the time of surgery for breast cancer.

I M Holdaway 1, B H Mason 1, A E Lethaby 1, J E Harman 1, J T France 1, B S Knox 1
PMCID: PMC2063357  PMID: 9020488

Abstract

Hormone measurements during the menstrual cycle were assessed in six premenopausal women undergoing breast cancer surgery and ten controls to determine whether the stress of diagnosis and surgery influenced cycle characteristics. There was hormonal evidence for normal ovulation in all cancer and control women, although the length of the luteal phase of the cycle was prolonged because of a delay in menstruation in two cancer patients. The timing of surgery in the cycle did not influence the hormonal data. The hormonal characteristics of the menstrual cycle thus appear to be normally preserved in women during the month in which breast cancer surgery is performed.

Full text

PDF
413

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Badwe R. A., Gregory W. M., Chaudary M. A., Richards M. A., Bentley A. E., Rubens R. D., Fentiman I. S. Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer. Lancet. 1991 May 25;337(8752):1261–1264. doi: 10.1016/0140-6736(91)92927-t. [DOI] [PubMed] [Google Scholar]
  2. Badwe R. A., Wang D. Y., Gregory W. M., Fentiman I. S., Chaudary M. A., Smith P., Richards M. A., Rubens R. D. Serum progesterone at the time of surgery and survival in women with premenopausal operable breast cancer. Eur J Cancer. 1994;30A(4):445–448. doi: 10.1016/0959-8049(94)90415-4. [DOI] [PubMed] [Google Scholar]
  3. France J. T., Graham F. M., Gosling L., Hair P., Knox B. S. Characteristics of natural conceptual cycles occurring in a prospective study of sex preselection: fertility awareness symptoms, hormone levels, sperm survival, and pregnancy outcome. Int J Fertil. 1992 Jul-Aug;37(4):244–255. [PubMed] [Google Scholar]
  4. Holdaway I. M., Mason B. H., Gibbs E. E., Rajasoorya C., Hopkins K. D. Seasonal changes in serum melatonin in women with previous breast cancer. Br J Cancer. 1991 Jul;64(1):149–153. doi: 10.1038/bjc.1991.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Lenton E. A., Landgren B. M., Sexton L. Normal variation in the length of the luteal phase of the menstrual cycle: identification of the short luteal phase. Br J Obstet Gynaecol. 1984 Jul;91(7):685–689. doi: 10.1111/j.1471-0528.1984.tb04831.x. [DOI] [PubMed] [Google Scholar]
  6. Ravdin P. M., Fritz N. F., Tormey D. C., Jordan V. C. Endocrine status of premenopausal node-positive breast cancer patients following adjuvant chemotherapy and long-term tamoxifen. Cancer Res. 1988 Feb 15;48(4):1026–1029. [PubMed] [Google Scholar]
  7. Senie R. T., Rosen P. P., Rhodes P., Lesser M. L. Timing of breast cancer excision during the menstrual cycle influences duration of disease-free survival. Ann Intern Med. 1991 Sep 1;115(5):337–342. doi: 10.7326/0003-4819-115-5-337. [DOI] [PubMed] [Google Scholar]
  8. Veronesi U., Luini A., Mariani L., Del Vecchio M., Alvez D., Andreoli C., Giacobone A., Merson M., Pacetti G., Raselli R. Effect of menstrual phase on surgical treatment of breast cancer. Lancet. 1994 Jun 18;343(8912):1545–1547. doi: 10.1016/s0140-6736(94)92942-4. [DOI] [PubMed] [Google Scholar]
  9. Yasumura T., Akami T., Mitsuo M., Oka T., Naitoh K., Yamamoto T., Honjyo H., Okada H. The effect of adjuvant therapy with or without tamoxifen on the endocrine function of patients with breast cancer. Jpn J Surg. 1990 Jul;20(4):369–375. doi: 10.1007/BF02470819. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES